Suspect arrested after historic town hall set alight – French media
The spire of the clock tower at Limoges city hall dramatically collapsed as it was engulfed in flames on Saturday.
another news portal
The spire of the clock tower at Limoges city hall dramatically collapsed as it was engulfed in flames on Saturday.
An oft-repeated phrase uttered by President Tweety McTreason after his 2020 election loss is poised to be turned against him in a matter of weeks
Senate nominee Ken Paxton (R-TX) has not publicly apologized to a conservative supporter who says she was the “only Black woman” at a rally his
In a weird way, I’ve been thinking about the idea of a Googlebook for well over a decade now — despite the fact that such
The UK wants to take a chunk out of Apple Pay, as the Competition and Markets Authority (CMA) moves to force Apple to open access to its 12-year-old
The mysterious and undeciphered Voynich manuscript has caused consternation among code-breakers, linguists and scholars of medieval literature for more than a century. But now experts
Stimulating the brain with ultrasound could help counter the delusions people experience in schizophrenia, a small trial finds. The trial involved transcranial ultrasound stimulation, in
Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have uncovered an immune pathway
FRASCATI, Italy — Observing Earth from space provides a much-needed insight into the evolution of our planet’s health. This is particularly important in the face
Targeting a deep brain region with sound waves may safely reduce delusions in people with schizophrenia and schizoaffective disorder, initial study results show.
The sixth report from Covid inquiry criticises the lack of PPE and the way patients were discharged from hospital.
Researchers at Brown University have discovered a molecular link between hunger and the formation of “reward” memories that play a role in alcohol addiction.
Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture